Candriam SCA’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
Other funds holding IMCR
Candriam SCA's IMCR Position: Q3 2026 in Review
Candriam SCA reduced its Immunocore (IMCR) stake by 1.8% in Q3 2026, selling an estimated $223K and leaving 366,492 shares worth $11.1M. The position accounts for 0.05% of the portfolio, ranked #260.
Candriam SCA first reported a position in IMCR in Q3 2022 and has held it in 17 quarters since. The position peaked at $21M in Q2 2023. 34 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.
- Candriam SCA held 366,492 shares of Immunocore worth $11.1M as of Q3 2026.
- Candriam SCA sold 6,554 Immunocore shares in Q3 2026, an estimated $223K.
- Immunocore made up 0.05% of Candriam SCA's portfolio in Q3 2026, its #260 holding.
- Candriam SCA first reported a position in Immunocore in Q3 2022 and has held it in 17 quarters since.
- Candriam SCA's Immunocore position peaked at $21M in Q2 2023.
- 34 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.
Based on Candriam SCA's 13F filing for Q3 2026, filed 3 Nov 2026.